These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31526279)

  • 1. Pharmacokinetic considerations for current state-of-the-art antidepressants.
    Wyska E
    Expert Opin Drug Metab Toxicol; 2019 Oct; 15(10):831-847. PubMed ID: 31526279
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.
    Kirchheiner J; Brøsen K; Dahl ML; Gram LF; Kasper S; Roots I; Sjöqvist F; Spina E; Brockmöller J
    Acta Psychiatr Scand; 2001 Sep; 104(3):173-92. PubMed ID: 11531654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression.
    Jann MW; Cohen LJ
    Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and drug metabolism of newer antidepressant agents.
    DeVane CL
    J Clin Psychiatry; 1994 Dec; 55 Suppl():38-45; discussion 46-7. PubMed ID: 7814357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of antidepressant pharmacokinetics and pharmacogenetics.
    Cohen LJ; De Vane CL
    Ann Pharmacother; 1996 Dec; 30(12):1471-80. PubMed ID: 8968460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of antidepressants: clinical aspects.
    Bertilsson L; Dahl ML; Tybring G
    Acta Psychiatr Scand Suppl; 1997; 391():14-21. PubMed ID: 9265947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and drug-metabolizing enzymes--expert group report.
    Meyer UA; Amrein R; Balant LP; Bertilsson L; Eichelbaum M; Guentert TW; Henauer S; Jackson P; Laux G; Mikkelsen H; Peck C; Pollock BG; Priest R; Sjöqvist F; Delini-Stula A
    Acta Psychiatr Scand; 1996 Feb; 93(2):71-9. PubMed ID: 8686486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants].
    Jeleń A; Sałagacka A; Balcerczak E
    Postepy Hig Med Dosw (Online); 2015 Jul; 69():753-62. PubMed ID: 26206991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2009 Sep; 21(3):399-400. PubMed ID: 19794364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic tests for controlling treatment with antidepressants].
    Bschor T; Baethge C; Hiemke C; Müller-Oerlinghausen B
    Nervenarzt; 2017 May; 88(5):495-499. PubMed ID: 28303314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidepressant pharmacokinetics during pregnancy].
    Maslovskiĭ SIu
    Eksp Klin Farmakol; 2013; 76(1):14-20. PubMed ID: 23461010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.
    Dahl ML; Sjöqvist F
    Ther Drug Monit; 2000 Feb; 22(1):114-7. PubMed ID: 10688272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.